Literature DB >> 22849494

Missed opportunities in early diagnosis of symptomatic colorectal cancer.

Maite Domínguez-Ayala1, Jonathan Díez-Vallejo, Angel Comas-Fuentes.   

Abstract

OBJECTIVE: delays in diagnosis of symptomatic colorectal cancer are a reality in our context. This study aims at identifying missed diagnostic opportunities, describing events, clinical clues and most common mistakes, and quantifying delays.
MATERIAL AND METHODS: an observational descriptive study was performed in order to review all case histories. Two experts reviewed the case histories of all the patients from the 4th Catchment Area of Asturias diagnosed with colorectal cancer in 2009. All data were analysed using bivariate and multivariate logistic regression.
RESULTS: full information on 119 patients out of 143 patients was collected. 34.45% had a clinical missed opportunity -confidence interval (CI) 95%: 30.92-39.68-. Outcomes show an average of 2.41 missed opportunities and 2.61 diagnostic clinical clues per patient. The number of patients with missed opportunities was significantly higher. The total amount of co-morbidities was higher in patients with missed opportunities (2.7). This was the main determinant. The main diagnostic key was iron-deficiency anaemia (46.3%). It produced the longest delay (300 days). Not having requested diagnostic tests was the most common mistake (43.3%). Having at least one missed opportunity entailed an average delay of 235.8 days between the first visit to the office and the referral to a consultant.
CONCLUSIONS: in clinical practice, missed opportunities to start a diagnostic assessment in patients with presumptive diagnosis of colorectal cancer are common. The most significant clinical clue and the one generating the longest delay is iron-deficiency anaemia. The diagnostic delay is important and is caused mainly by not identifying symptoms.

Entities:  

Mesh:

Year:  2012        PMID: 22849494     DOI: 10.4321/s1130-01082012000700002

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  7 in total

1.  Curative resectability of gastrointestinal cancer identified from iron deficiency anemia.

Authors:  Kenta Kawasaki; Yasuo Hamamoto; Masayasu Horibe; Kenji Shimura; Akira Nakamura; Takanori Kanai; Hiromasa Takaishi
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

2.  Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data.

Authors:  Mark C Hornbrook; Ran Goshen; Eran Choman; Maureen O'Keeffe-Rosetti; Yaron Kinar; Elizabeth G Liles; Kristal C Rust
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

Review 3.  Colorectal cancer diagnosis: Pitfalls and opportunities.

Authors:  Pablo Vega; Fátima Valentín; Joaquín Cubiella
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

4.  Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate.

Authors:  Bin Liu; Wen-Yi Sun; Chen-Yang Zhi; Tian-Cheng Lu; Hai-Mei Gao; Jian-Hua Zhou; Wei-Qun Yan; Hai-Cheng Gao
Journal:  Exp Ther Med       Date:  2013-10-14       Impact factor: 2.447

5.  Cancer suspicion in general practice, urgent referral, and time to diagnosis: a population-based GP survey nested within a feasibility study using information technology to flag-up patients with symptoms of colorectal cancer.

Authors:  Elaine Kidney; Sheila Greenfield; Lindy Berkman; George Dowswell; William Hamilton; Sally Wood; Tom Marshall
Journal:  BJGP Open       Date:  2017-10-04

6.  Changes in the quality of care of colorectal cancer in Estonia: a population-based high-resolution study.

Authors:  Heigo Reima; Jaan Soplepmann; Anneli Elme; Mari Lõhmus; Rena Tiigi; Denis Uksov; Kaire Innos
Journal:  BMJ Open       Date:  2020-10-08       Impact factor: 2.692

7.  Missed Opportunities for the Diagnosis of Colorectal Cancer.

Authors:  Laura A Siminoff; Heather L Rogers; Sonja Harris-Haywood
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.